Published in Eur J Epidemiol on January 01, 2001
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis (2013) 1.65
HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health (2009) 1.62
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study. Eur J Epidemiol (2007) 1.07
Epidemiology of hepatitis A virus infections, Germany, 2007-2008. Emerg Infect Dis (2009) 1.04
Seroepidemiology of hepatitis a in the croatian population. Hepat Mon (2011) 1.02
A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers. PLoS One (2012) 1.00
Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect (2008) 0.98
Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups. BMC Public Health (2008) 0.95
High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: a prospective screening analysis of 28,809 patients. PLoS One (2012) 0.91
Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004. Epidemiol Infect (2006) 0.88
Outbreak of hepatitis A in two federal states of Germany: bakery products as vehicle of infection. Epidemiol Infect (2006) 0.86
Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg. Epidemiol Infect (2006) 0.85
Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany. Med Microbiol Immunol (2013) 0.79
[The German Health Survey. 1997/98]. Gesundheitswesen (1998) 1.65
[The Federal Health Survey: response, composition of participants and non-responder analysis]. Gesundheitswesen (1999) 1.41
[Prevalence of serological markers of the hepatitis B virus in the out-patient population of the city of Vigo]. Aten Primaria (1992) 1.40
Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveys. Am J Epidemiol (1979) 1.35
Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol (1994) 1.02
Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol (1999) 0.93
Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation. Infection (1994) 0.93
Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis (1995) 0.89
Hepatitis A as an occupational hazard. Vaccine (1992) 0.88
Prevalence of hepatitis B and C markers in the south-east of Spain: an unlinked community-based serosurvey of 2,203 adults. Scand J Infect Dis (1996) 0.81
Prevalence of hepatitis A antibodies in Swiss travellers. Eur J Epidemiol (1993) 0.81
The shift in prevalence of hepatitis A immunity in Flanders, Belgium. Acta Gastroenterol Belg (1998) 0.79
Estimated risk of transmission of hepatitis C virus by blood transfusion. Vox Sang (1998) 0.79
Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., Germany. Zentralbl Bakteriol (1995) 0.78
Factors associated with hepatitis B infection. Int J STD AIDS (1993) 0.76
The prevalence of hepatitis B in Sweden; a statistical serosurvey of 3381 Swedish inhabitants. Epidemiol Infect (1997) 0.76
[Prevalence and follow-up of hepatitis C virus infection in pregnancy]. Z Geburtshilfe Neonatol (1998) 0.76
[Prevalence of hepatitis A virus antibodies in hospital personnel]. Gesundheitswesen (1994) 0.75
[High percentage of isolated anti-HBc-positive persons among prisoners]. Gesundheitswesen (1997) 0.75
[Sequelae of imported tropical diseases in Germany]. Versicherungsmedizin (1994) 0.75
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol (1995) 3.35
Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation (1992) 3.04
Molecular characterization of the first Aichi viruses isolated in Europe and in South America. Arch Virol (2006) 2.60
Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology (1995) 2.25
Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites. Drug Metab Dispos (1984) 2.01
Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology (1996) 2.01
Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill (2010) 1.95
A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. Euro Surveill (2013) 1.93
Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol (2008) 1.80
[The taxonomic problem of Clostridium sordellii and Clostridium bifermentans]. Med Dosw Mikrobiol (1966) 1.72
Indigenous hepatitis E virus infection of a plasma donor in Germany. Vox Sang (2009) 1.60
Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J Virol (1999) 1.54
The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect (2004) 1.49
Detection and characterization of norovirus outbreaks in Germany: application of a one-tube RT-PCR using a fluorogenic real-time detection system. J Med Virol (2004) 1.44
The heart in sickle cell anemia. The Cooperative Study of Sickle Cell Disease (CSSCD). Chest (1995) 1.42
Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species. J Med Virol (2001) 1.42
Increase in norovirus activity reported in Europe. Euro Surveill (2006) 1.41
Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut (2009) 1.40
Genetic diversity and recombination of murine noroviruses in immunocompromised mice. Arch Virol (2007) 1.37
A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis (2008) 1.29
Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis (1995) 1.28
Detection of enteric viruses and bacterial indicators in German environmental waters. Arch Virol (2005) 1.25
Human plasma levels of some anti-migraine drugs. Headache (1976) 1.23
Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment. Hepatology (2000) 1.23
Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr (2000) 1.22
Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol (1996) 1.21
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology (1997) 1.20
Structural and functional changes of the duodenum in human norovirus infection. Gut (2008) 1.18
Sequence comparison of echovirus type 30 isolates to other enteroviruses in the 5'noncoding region. J Med Virol (1995) 1.17
Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. J Virol (1997) 1.17
Core particles of hepatitis B virus as carrier for foreign epitopes. Adv Virus Res (1998) 1.17
Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology (1992) 1.15
Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J Virol Methods (1994) 1.14
Genotyping of measles virus isolates from central Europe and Russia. J Med Virol (1999) 1.12
Differentiation of vaccine and wild-type polioviruses using polymerase chain reaction and restriction enzyme analysis. Arch Virol (1994) 1.11
Short report: simultaneous occurrence of Dobrava, Puumala, and Tula Hantaviruses in Slovakia. Am J Trop Med Hyg (1999) 1.11
Data quality of 5 years of central norovirus outbreak reporting in the European Network for food-borne viruses. J Public Health (Oxf) (2007) 1.08
Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003. Epidemiol Infect (2006) 1.07
Rapid detection of influenza A neuraminidase subtypes by cDNA amplification coupled to a simple DNA enzyme immunoassay. Arch Virol (1994) 1.07
Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data. J Infect Dis (2009) 1.06
Human cytomegalovirus (HCMV) encephalitis in an immunocompetent young person and diagnostic reliability of HCMV DNA PCR using cerebrospinal fluid of nonimmunosuppressed patients. J Clin Microbiol (1998) 1.05
Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Braz J Med Biol Res (1999) 1.04
Genetic variability within the VP1 coding region of echovirus type 30 isolates. Arch Virol (2000) 1.04
Clinical characterization of Dobrava hantavirus infections in Germany. Clin Nephrol (2001) 1.04
Enhanced surveillance during a large outbreak of bloody diarrhoea and haemolytic uraemic syndrome caused by Shiga toxin/verotoxin-producing Escherichia coli in Germany, May to June 2011. Euro Surveill (2011) 1.03
[STEP--standardized assessment of elderly people in primary care]. Dtsch Med Wochenschr (2004) 1.03
Detection of sequences of TT virus, a novel DNA virus, in German patients. J Gen Virol (1998) 1.02
Pneumococcal disease surveillance in Europe. Euro Surveill (2006) 1.02
A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect (2008) 1.02
[Not Available]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2002) 1.02
[Biochemical measures in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2007) 1.00
Aseptic meningitis in Germany associated with echovirus type 13. BMC Infect Dis (2001) 1.00
Heart-rate variability in children. Spectral analysis of developmental changes between 5 and 24 years. Can J Physiol Pharmacol (1987) 1.00
Maternal occupational exposure to chemical substances and the risk of infants small-for-gestational-age. Am J Ind Med (1999) 0.98
[The norovirus-epidemic in Berlin - clinic, epidemiology, and prevention]. Z Gastroenterol (2004) 0.98
A foodborne norovirus outbreak due to manually prepared salad, Austria 2006. Infection (2007) 0.98
Seroepidemiology of TT virus, GBC-C/HGV, and hepatitis viruses B, C, and E among women in a rural area of Tanzania. J Med Virol (2000) 0.96
Community-wide outbreak of enteroviral illness caused by echovirus 30: a cross-sectional survey and a case-control study. Pediatr Infect Dis J (1999) 0.96
Detection of tick-borne encephalitis virus RNA in ticks (Ixodes ricinus) by the polymerase chain reaction. J Virol Methods (1993) 0.95
Genetic characterization of a new hantavirus detected in Microtus arvalis from Slovakia. Virus Genes (1995) 0.95
Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication. Hepatology (1999) 0.95
Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease. Hepatology (1996) 0.94
Postanesthetic necrotic defect. Oral Surg Oral Med Oral Pathol (1975) 0.94
Radionuclide assessment of right and left ventricular exercise reserve after total correction of tetralogy of Fallot. Am J Cardiol (1980) 0.94
Molecular characterization of human astroviruses isolated in Brazil, including the complete sequences of astrovirus genotypes 4 and 5. Arch Virol (2006) 0.94
Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-lactoglobulin. FEBS Lett (1997) 0.94
Heterogeneity of hepatitis B virus C-gene sequences: implications for amplification and sequencing. J Hepatol (1993) 0.94
Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters. J Hepatol (1997) 0.94
Life-threatening Dobrava hantavirus infection with unusually extended pulmonary involvement. Clin Nephrol (2004) 0.93
Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Nahrung (1995) 0.93
Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region. Arch Virol (1994) 0.92
In vitro replication of hepatitis C virus in a human lymphoid cell line (H9) J Hepatol (1994) 0.92
Tissue distribution, disposition, and metabolism of cyclosporine in rats. Drug Metab Dispos (1987) 0.92
An outbreak of viral meningitis associated with a public swimming pond. Epidemiol Infect (2005) 0.91
Nucleosides and nucleotides: natural bioactive substances in milk and colostrum. Br J Nutr (2000) 0.91
Molecular characterization of human astroviruses in Germany. Arch Virol (2001) 0.91
Characterization of nucleotide sequences from European hepatitis C virus isolates. Gene (1991) 0.91
Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J Gen Virol (2000) 0.90
[Laboratory tests in The Child and Adolescent Health Survey]. Gesundheitswesen (2002) 0.90
Detection of human hantavirus infections in Lithuania. Infection (2005) 0.90
[German Health survey 1997/98: immune status against poliomyelitis]. Dtsch Med Wochenschr (2000) 0.90
Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine (1998) 0.90
Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Lett (1996) 0.90
[Prevalence of hantavirus infections in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2004) 0.90
Repair of aortic coarctation in the first three months of life: immediate and long-term results. Ann Thorac Surg (1986) 0.90
Vaccine-associated cases of poliomyelitis over a 30 year period in East Germany. Eur J Epidemiol (1995) 0.89
Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis (1995) 0.89
Pneumococcal vaccination policy in Europe. Euro Surveill (2005) 0.89
Comparative investigation of the long non-coding M-F genome region of wild-type and vaccine measles viruses. Arch Virol (1997) 0.89
[First evaluation of the surveillance systems of notifiable diseases under the infectious disease control law in Germany]. Gesundheitswesen (2003) 0.88
Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype. Arch Virol (1995) 0.88
An evidence-based approach to assessing older people in primary care. Occas Pap R Coll Gen Pract (2002) 0.88
Comparative inhibition of hepatitis B virus DNA polymerase and cellular DNA polymerases by triphosphates of sugar-modified 5-methyldeoxycytidines and of other nucleoside analogs. Antimicrob Agents Chemother (1991) 0.88
Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus. Viral Immunol (2002) 0.88
Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak. Arch Virol (1994) 0.87
Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Vox Sang (1998) 0.87
Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill (2010) 0.87
Rational use of diagnostic tools in hepatitis C. J Hepatol (1996) 0.87